Staff Profile
Research
I completed my integrated Masters at the University of Liverpool during which I undertook a 1 year placement at GSK, Stevenage. Following this I moved to Newcastle University where I completed my PhD studying cellular assays from patients undergoing immune checkpoint inhibitor (ICI) therapy with a focus on comparing those that do or do not develop immune-related adverse events (irAEs). Upon completion of my doctoral studies, I have taken up a post-doc role which aims to characterise and compare the synovium of patients ICI-inflammatory arthritis with different types of spontaneous arthritis.
Teaching
Previously helped to supervise 2 MRes students
Publications
-
Article
- Williams KC, Gault A, Anderson AE, Stewart CJ, Lamb CA, Ally Speight R, Rajan N, Plummer R, Pratt AG. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations. Frontiers in Immunology 2023, 14 - 2023.